A Study to Evaluate the Efficacy and Safety of AD-209

Clinical trial NCT05631990 · COMPLETED

Trial details

NCT number: NCT05631990
Sponsor: Addpharma Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hypertension, Essential

Start date: 2023-04-05
Primary completion: 2023-11-27
Enrollment: 221

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.